The upregulation of interleukin (IL)-1β maturation, IL-18 secretion, and caspase-1 cleavage in response to various NLRP3 activators was observed in monocyte-derived macrophages from T2D patients (Lee et al. 2013). The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.